1478 A Phase I Study of Personalized Adoptive TCR T Cell Therapy in Patients with Solid Tumors: Safety, Efficacy, and T Cell Trafficking to Tumors of Non-Virally Gene Edited T Cells Susan Foy , Kyle Jacoby , Daniela Bota , Theresa Hunter , Adam Schoenfeld , Zheng Pan , Eric Stawiski , Yan Ma , William Lu , Songming Peng , Clifford Wang , Benjamin Yuen , Olivier Dalmas , Katharine Heeringa , Barbara Sennino , Andy Conroy , Michael Bethune , Ines Mende , William White , Monica Kukreja , Swetha Gunturu , Emily Humphrey , Adeel Hussaini , Duo An , Boi Quach , Alphonsus Ng , Yue Lu , Chad Smith , Katie Campbell , Daniel Anaya , Lindsey Skrdlant , Eva Huang , Ventura Mendoza , Jyoti Mathur , Luke Dengler , Bhamini Purandare , Robert Moot , Michael Yi , Roel Funke , Alison Sibley , Todd Stallings-Schmitt , David Oh , Bartosz Chmielowski , Mehrdad Abedi , Yuan , Jeff Sosman , Sylvia Lee , Claire Williams , Sean Kim , Matthwe Keefe , Michael Leon , Youngmi Kim , Jason Reeves , Wes Goldman , David Baltimore , James Heath , Alex Franzusoff , Antoni Ribas , Arati Rao , Stefanie Mandl JOURNAL FOR IMMUNOTHERAPY OF CANCER（2022）
AI 理解论文
溯源树
样例
